Physician

John Whitesell Miller, M.D.

According to 2025 Medicare claims, John Miller, M.D. (NPI: 1578524286) practices ophthalmology in the Beaumont-Port Arthur, TX market, with the plurality of this provider's patient population coming from Orange, TX. This provider's primary affiliated billing organization is EYE CENTERS OF SOUTHEAST TEXAS LLP (NPI: 1124003454; TIN: 760549217) and primary practice location at 77701-4754.

Miller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 317 traditional Medicare patients, billed 5,242 HCPCS/CPT codes, and received $581,240 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 255 prescription claims across 90 beneficiaries totaling $26,588 in drug costs, led by Ilevro (Nepafenac). Open Payments data shows 10 records totaling $261. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $25,901 and ending at $26,588. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$343K$687K2015 Medicare payment: $635,271 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $646,240 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $680,915 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $657,978 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $686,831 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $535,028 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $547,382 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $599,909 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $515,637 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $581,240 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155794,884$635,271
20165805,208$646,240
20175044,786$680,915
20184754,474$657,978
20194524,482$686,831
20204163,752$535,028
20213573,200$547,382
20223523,226$599,909
20233494,034$515,637
20243175,242$581,240

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$32K2015 Drug cost: $25,901 (USD; Tot_Drug_Cst)2016 Drug cost: $19,001 (USD; Tot_Drug_Cst)2017 Drug cost: $19,935 (USD; Tot_Drug_Cst)2018 Drug cost: $20,772 (USD; Tot_Drug_Cst)2019 Drug cost: $32,315 (USD; Tot_Drug_Cst)2020 Drug cost: $28,449 (USD; Tot_Drug_Cst)2021 Drug cost: $26,398 (USD; Tot_Drug_Cst)2022 Drug cost: $29,557 (USD; Tot_Drug_Cst)2023 Drug cost: $23,734 (USD; Tot_Drug_Cst)2024 Drug cost: $26,588 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201576233$25,901
201654203$19,001
201762221$19,935
201864202$20,772
201984223$32,315
202077191$28,449
202166207$26,398
202287231$29,557
202379229$23,734
202490255$26,588

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg36220$641
67028Injection of drug into eye160803$81
J7999Compounded drug, not otherwise classified119549$66
92012Established patient problem focused exam of visual system184344$58
92134Imaging of retina229644$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IlevroNepafenac301,263$11,558
Bromfenac SodiumBromfenac Sodium14648$2,115
Prednisolone AcetatePrednisolone Acetate481,452$1,668
LatanoprostLatanoprost291,925$434
Diclofenac SodiumDiclofenac Sodium451,294$338

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$261Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Whitesell Miller, M.D.?

Tedicare shows public-source Medicare data for John Whitesell Miller, M.D. (NPI 1578524286), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Whitesell Miller, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Whitesell Miller, M.D.?

John Whitesell Miller, M.D. is linked to EYE CENTERS OF SOUTHEAST TEXAS LLP (billing NPI 1124003454) in the available physician profile data.

Does John Whitesell Miller, M.D. have Open Payments data?

John Whitesell Miller, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.